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Caspase-11 is an inducible caspase involved in the regulation of cell death and inﬂammation. In the
present study, we examined whether apoptosis signal-regulating kinase 1 (Ask1)-mediated signal-
ing pathway is involved in the expression of caspase-11 induced by lipopolysaccharide (LPS). We
found that the induction of caspase-11 was suppressed by the inhibitors of NADPH oxidase (Nox)
or knockdown of Nox4 that acts downstream of toll-like receptor 4 and generates Ask1-activating
reactive oxygen species. Overexpression of dominant negative tumor necrosis factor receptor asso-
ciate factor 6 also suppressed the induction of caspase-11. Importantly, knockdown or dominant
negative form of Ask1 suppressed the induction of caspase-11 following LPS stimulation. Taken
together, our results show that Ask1 regulates the expression of caspase-11 following LPS
stimulation.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Caspase-11 is a murine caspase whose expression is regulated
mainly at a transcriptional level [1]. It is induced by various cellu-
lar insults and under pathological conditions such as lipopolysac-
charide (LPS)-induced septic shock, brain ischemia, experimental
autoimmune encephalomyelitis, and 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine-induced Parkinson’s disease models in mice
[1–4]. Following induction, it activates caspase-1 by direct interac-
tion and caspase-3 by proteolytic cleavage. Thus caspase-11 can
regulate both inﬂammatory response via cytokine maturation
and apoptosis via caspase-3 activation depending on the cellular
context [2,5]. Since caspase-11 is involved in many disease condi-
tions with pathological apoptosis and inﬂammation, understand-
ing of its induction mechanism is necessary to develop
therapeutics targeting caspase-11 for the treatment of the related
diseases. It was reported that proinﬂammatory mediators like
LPS and interferon c (IFNc) induce the expression of caspase-11
by activating nuclear factor (NF)-jB and signal transducer and acti-
vator of transcription 1 (STAT1), respectively [6]. A following study
showed that LPS-induced activation of NF-jB leading to caspase-
11 expression is mediated by a signaling cascade involving Toll-
like receptor 4 (TLR4)/myeloid differentiation primary responsechemical Societies. Published by E
Gwangjin-gu, Seoul 143-747,gene 88 (MyD88) [7]. It was also reported that the activation of
p38 mitogen-activated protein kinase (MAPK) in C6 rat glial cells,
c-Jun N-terminal kinase (JNK) in mouse embryonic ﬁbroblasts
(MEFs) and C/EBP homologous protein in mice was required for
the induction of caspase-11 [8–10]. Because of its inducibility, cas-
pase-11 can be a good target of therapeutics against many diseases
accompanying excessive apoptosis and inﬂammation.
Apoptosis signal-regulating kinase 1 (Ask1) is a mitogen-acti-
vated protein kinase kinase kinase (MAPKKK) activated by various
cell damaging signals including LPS, reactive oxygen species (ROS),
endoplasmic reticulum stress, inﬂux of calcium ions, and mole-
cules like tumor necrosis factor a (TNF a) and Fas ligand [11]. Fol-
lowing activation, Ask1 regulates various cellular events like cell
death, differentiation, and TLR4-mediated innate immunity
[11,12]. In unstimulated cells, Ask1 activation is suppressed by thi-
oredoxin (Trx) but following oxidative stress or engagement of
TLR4 or TNF receptor 1, Trx dissociates from the Ask1/TNF receptor
associated factor 2/6 (TRAF2/6) complex and activates Ask1 [11].
For this activation, ROS has been reported to be a common second
messenger [12]. After LPS stimulation, it was suggested that ROS is
generated by NADPH oxidase 4 (Nox4)-containing Nox complex
that directly interacts with TLR4 [13]. Ultimately, the activated
Ask1 activates p38 MAPK and JNK [11].
Since caspase-11 and Ask1 are activated by similar stimuli,
share common signaling molecules, and exhibit similar functions
in stress and immune response, we examined whether Ask1 plays
a role in the induction of caspase-11. We report here the evidencelsevier B.V. All rights reserved.
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stimulation.
2. Materials and methods
2.1. Reagents and antibodies
Anti-caspase-11 antibodies were from Abcam (Cambridge, UK),
anti-Ask1 antibodies from Cell signaling Technology (Danvers,
MA). Secondary antibodies were from Jackson ImmunoResearch
Laboratories (West Grove, PA). Cytokines were purchased from
Millipore (Billerica, MA). Cell culture media, fetal bovine serum
(FBS) and other culture supplements were from JBI (Daegu, Korea).
All other reagents were from Sigma–Aldrich unless stated other-
wise (St. Louis, MO).
2.2. Cell culture and transfection
MEFs were cultured as described previously [9]. Transfection
was carried out using TransIT-LT reagent according to the manu-
facturer’s protocol (Mirus Bio, Madison, WI). To isolate peritoneal
macrophages, mice were peritoneally injected with thioglycollate
medium (4%, 1 ml/mouse). After 4–6 days, mice were sacriﬁced
and peritoneal exudate cells were collected using an 18-guage nee-
dle and 1% FBS/RPMI 1640 medium. Cells were plated and incu-
bated for 3 h and unattached cells were washed away. Astrocytes
were cultured from ICR mouse pups at postnatal day 1 as described
previously [14] with minor modiﬁcations.
2.3. Immunoblots
Proteins (25–30 lg) prepared from MEFs were subjected to 10%
SDS–polyacrylamide gel electrophoresis and immunoblot assay
following standard protocols.
2.4. Gene knockdown by oligonucleotide siRNA
Small interfering RNA (siRNA) duplexes for Nox4 (siRNA
1392781) and Ask1 (siRNA 100233), and negative controls were
purchased from Bioneer (Daejeon, Korea, sequences available upon
request). For siRNA transfection, 100 pmoles of oligonucleotide
siRNA duplexes were mixed with 5 ll Lipofectamine 2000
(Invitrogen, Carlsbad, CA) in 200 ll TOM and added onto MEFs
(5  105/ml) grown on 35 mm dish. After 4 h incubation, the
medium was replaced with normal growth medium.
2.5. Dual luciferase assay
MEFs (5  105/ml) grown on 24-well culture plates were
transfected with caspase-11 promoter-luciferase plus pRL-TK
expression vectors (5:1) using TransIT-LT1 transfection reagents.
Following stimulation or co-transfection with other plasmid DNAs
such as Ask1 expression vector, the cells were lysed and sequen-
tially measured for the ﬁreﬂy and Renilla luminescence using Pro-
mega Dual-Luciferase Reporter Assay kit (Madison, WI) according
to the manufacturer’s manual.Fig. 1. Cells from the TLR4-defective mice do not express caspase-11 following LPS
stimulation. (A) MEFs from control C3H/HeN (HeN) and TLR4-defective C3H/HeJ
(HeJ) mice were stimulated with LPS (100 ng/ml), IL-1b (50 ng/ml), TNFa (10 ng/ml),
or IFNc (50 ng/ml) for 6 h and then examined for the caspase-11 protein level by
immunoblot assay. (B) Astrocytes and peritoneal macrophages from control C3H/
HeN and C3H/HeJ mice were stimulated with LPS (100 ng/ml) for 6 h and then
processed for caspase-11 immunoblot assay. Tubulin blots served as loading
controls. Representative blots out of three independent experiments are shown.2.6. RT-PCR
Total RNA from tissues and cultured cells was prepared using
RNeasy minikit (Qiagen, Valenia, CA). cDNA was synthesized using
the Moloney Murine Leukemia Virus Reverse Transcriptase (Pro-
mega, Madison, WI) according to the manufacturer’s protocol. For
the detection of caspase-11 mRNA, forward (50-AGAAGTCTTACG-
GAGTACC-30) and reverse (50-TGGTGTTCTGAGAGTGCAGC-30) andfor Nox4 mRNA, forward (50-GAAGCCCATTTGAGGAGTCA-30) and
reverse (50-GGGTCCACAGCAGAAAACTC-30) primer pairs were used.
Mouse b-actin RT-PCR primer set was purchased from Stratagene
(La Jolla, CA). Annealing temperature for caspase-11 and b-actin
reaction was 54 C and for Nox4, 57 C.
3. Results
To examine a possible role of Ask1 in the induction of caspase-
11 following LPS stimulation, we ﬁrst conﬁrmed the involvement
of TLR4 which is an LPS receptor and known to convey signal to
activate Ask1 [11]. Jung et al. [7] have shown that caspase-11
mRNA is not detected in the microglia of C3H/HeJ mice that have
spontaneous mutation in TLR4 gene. Consistent with this earlier
observation, caspase-11 induction was not detected in the MEFs
of C3H/HeJ mice at a protein level following LPS stimulation
(Fig. 1A). However, caspase-11 induction by interleukin 1b (IL-
1b), TNFa, or IFNc was normal in the MEFs of C3H/HeJ mice
(Fig. 1A). The requirement of TLR4 in the LPS-induced expression
of caspase-11 was also conﬁrmed in the astrocytes and peritoneal
macrophages cultured from C3H/HeJ mice (Fig. 1B). These results
show that TLR4 mediates the LPS signal to induce caspase-11 in
MEFs.
It has been reported that Ask1 is activated by ROS and the stim-
ulation of TLR4 can generate ROS by Nox complex interacting with
the TLR4 [12,13]. To determine whether Nox-mediated generation
of ROS is required for the induction of caspase-11, we ﬁrst exam-
ined whether a general antioxidant like N-acetylcysteine (NAC)
can attenuate the LPS-induced expression of caspase-11. The MEFs
pretreated with NAC exhibited reduced level of caspase-11 protein
following LPS stimulation compared to the MEFs stimulated with
LPS alone (Fig. 2A). This suggests that the ROS generated by LPS
stimulation play a role in the signaling for the caspase-11 induc-
tion. To identify a possible source of these ROS, the MEFs were pre-
treated with inhibitors of Nox, i.e., diphenyleneiodonium (DPI) and
apocynin and then stimulated with LPS, and the expression level of
caspase-11 was examined. As shown in Fig. 2B, both DPI and
apocynin efﬁciently suppressed the LPS-induced expression of cas-
pase-11, indicating activation of Nox and the production of ROS
can mediate the induction signaling for caspase-11. Since there
has been arguments regarding the speciﬁcity of apocynin and DPI
as Nox inhibitors [15], we examined the knockdown effect of
Fig. 2. Nox4 is involved in the TLR4 signaling for the caspase-11 induction. (A) MEFs were 30 min pretreated with NAC at the indicated millimolar concentrations and then
treated with LPS (100 ng/ml) for further 6 h. The cells were then processed for the caspase-11 immunoblots. (B) MEFs were incubated with LPS (100 ng/ml) for 6 h following
30 min preincubation with Nox inhibitors like DPI (10 lM) and apocynin (100 lM) and then examined by caspase-11 immunoblotting. (C) MEFs (5  105 cells) were
transfected with negative control (CTL) or Nox4 siRNA duplexes (200 pmoles) and further incubated for 40 h. Then the mRNA levels of Nox4 and caspase-11 were monitored
by RT-PCR of the indicated ampliﬁcation cycles. Ampliﬁcation of b-actin mRNA served as an internal control. The reduction of caspase-11 protein level was conﬁrmed by
immunoblots (D). A tubulin blot was used as a loading control. (A–D) Consistent results were obtained from three independent experiments.
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further conﬁrm the involvement of Nox in the caspase-11 induc-
tion signaling. As shown in Fig. 2C and D, the knockdown of
Nox4 attenuated the induction of caspase-11 at both mRNA and
protein levels after LPS stimulation. These results suggest that
the activation of Nox4 following TLR4 engagement by LPS mediates
a signal to induce caspase-11.
It has been shown that TRAF6 activates Ask1 by forming a com-
plex following TLR4 activation and the formation of this TRAF6–
Ask1 complex is ROS-dependent [12]. Although there has been
no direct evidence showing activation of Nox4 is the source ROS re-
quired for the TRAF6–Ask1 complex, involvement of Nox4 in TLR4
signaling for the caspase-11 induction prompted us to examine
whether TRAF6 plays a role in the regulation of caspase-11 induc-
tion following Nox activation. To examine whether TRAF6 is in-
volved in the induction of caspase-11, wild-type or N-terminal
deletion (amino acids 1–288) dominant negative TRAF6 [16] was
overexpressed in the MEFs and the level of caspase-11 proteinFig. 3. Dominant negative TRAF6 suppressed the induction of caspase-11. (A) MEFs
were transfected with empty vectors (control, CTL), TRAF6 or DN-TRAF6 expression
vectors, incubated for 18 h and then stimulated with LPS (100 ng/ml) for further
6 h. (B) MEFs were transfected with control or TRAF6 expression vectors. At 18 h
after the transfection, the cells were 30 min preincubated with NAC (20 mM)
followed by LPS (100 ng/ml) incubation for further 6 h. The level of caspase-11 was
then examined by immunoblot assay. Similar results were obtained in three
independent experiments.was compared following LPS stimulation. As shown in Fig. 3A,
overexpression of the dominant negative TRAF6 attenuated the
expression of casapse-11, indicating TRAF6 plays a role to induce
caspase-11. The activation of TRAF6 in the caspase-11 induction
signaling seemed to be downstream of ROS generation since the
suppression of caspase-11 induction by NAC was reversed by over-
expression of TRAF6 (Fig. 3B).
It has been reported that ROS generated following TLR4 activa-
tion triggers the formation of TRAF6–Ask1 complex and this results
in the activation of Ask1 [12]. Since we observed the signaling mol-
ecules upstream of Ask1 were involved in the regulation of cas-
pase-11 induction, we then examined whether Ask1 plays a role
to induce caspase-11. First, we compared the effect of overexpres-
sion of wild-type vs. dominant negative form of Ask1 (K709M) on
the promoter activity of caspase-11. As shown in Fig. 4A, overex-
pression of the wild-type Ask1 activated the caspase-11 promoter
while that of the dominant negative Ask1 did not. Furthermore,
knockdown of Ask1 suppressed the LPS-induced upregulation of
caspase-11 (Fig. 4B), conﬁrming the role of Ask1 in the induction
of caspase-11. Consistently with other reports [11,12], the activa-
tion of Ask1 appeared to be downstream of TRAF6 activation since
the suppression of caspase-11 induction by dominant negative
TRAF6 was reversed by overexpression of Ask1 (Fig. 4C). These re-
sults indicate that Ask1 mediates the caspase-11 induction signal-
ing after LPS stimulation.4. Discussion
In the present study we showed evidence indicating that Ask1
mediates the LPS-induced signal to upregulate caspase-11 expres-
sion in MEFs. Following LPS stimulation, we observed evidence of
involvement of TLR4–Nox4–ROS–TRAF6–Ask1 signaling cascade
in the induction of caspase-11. Previously, a signaling cascade for
the caspase-11 induction has been studied only partially from
the LPS receptor to NF-kB in several studies. In the upstream of
the caspase-11 induction signaling, a requirement of TLR4 in the
LPS-induced caspase-11 expression in microglia has been reported
[7]. In this report, a signaling via MyD88-IRAK-TRAF6 has been
implicated to mediate the TLR4 signal for the induction of cas-
apse-11 but this was not directly tested in the study [7]. Among
the downstream MAPKs, p38 MAPK and JNK have been shown to
Fig. 4. Ask1 is involved in the LPS-signaling for caspase-11 induction. A. MEFs were
co-transfected with expression plasmids of wild-type Ask1 (WT Ask1) or K709M
dominant negative Ask1 (DN Ask1) together with caspase-11-promoter-pGL and
pRL-TK expression vectors and incubated for 24 h. Activation of casapse-11
promoter was monitored without LPS stimulation by dual luciferase assay. Results
were presented as means ± S.D. determined from two independent experiments.
* WT vs. DN Ask1, P < 0.01 by student’s t-test. (B) MEFs were transfected with siRNA
duplexes of negative control (CTL) or Ask1, incubated for 36 h and then stimulated
with LPS for further 6 h. Then the level of caspase-11 was examined by immuno-
blots. (C) MEFs were transfected with control or Ask1 expression vectors with or
without dominant negative TRAF6. Then the cells were stimulated with LPS
(100 ng/ml) for 6 h and then processed for caspase-11 immunoblots. Similar results
were obtained in three independent experiments.
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was further supported by the observation that an inhibitor of
p38 MAPK attenuated the cell death and induction of caspase-11
in the rat substantia nigra following LPS injection [17]. Ask1 has
been also known to activate p38 MAPK [12]. Therefore, it is highly
probable that caspase-11 is induced by LPS via TLR4–Nox4–ROS–
TRAF6–Ask1–p38 signaling axis. However, the signaling events
linking TLR4 engagement and MAPK activation speciﬁc for the cas-
pase-11 have been ﬁrst shown in the present study. Our data show
that ROS as a signaling molecule and Ask1 convey LPS–TLR4 signal
to induce caspase-11 although involvement of other MAPKKKs
cannot be ruled out.
MAPKKKs downstream of TLR4-TRAF6 other than Ask1 can be
transforming growth factor-beta-activated kinase 1 (TAK1) or
MAP/extracellular signal-regulated kinase kinase kinase 3
(MEKK3) [11]. Since caspase-11 promoter has been known to be
activated by NF-jB that is a direct target of TAK1 [6,14], one can
speculate that TAK1 is activated downstream of TLR4–TRAF6 and
activates NF-jB via IKK activation [18]. However, Mochida et al.
[19] reported that Ask1 inhibits IL-1-induced NF-jB activation by
disrupting TRAF6–TAK1 interaction. If this is also true in case of
LPS-induced activation of Ask1, a signal divergence for TAK1 acti-vation may not be possible. However, both NF-jD and Ask1 do acti-
vate following LPS stimulation [14,20], the possibility that Ask1
suppresses NF-jD activation by disrupting TRAF6–TAK1 interac-
tion is very low in LPS-signaling. Thus, involvement of MAPKKKs
other than Ask1 in the LPS-induced caspase-11 expression remains
to be studied.
Transcription factors for the caspase-11 have been reported to
be NF-jB or STAT1 following stimulation with LPS or IFNc, respec-
tively [13]. It has been shown that LPS-induced activation of Ask1
leads to the activation of p38 MAPK but not JNK [18] and p38
MAPK does not directly activate NF-jB although a pharmacological
inhibition of p38 MAPK attenuates the NF-jB activation [20].
Therefore, Ask1-induced expression of caspase-11 may be medi-
ated by transcription factor(s) other than NF-jB. It has been re-
ported that p38 MAPK regulates the expression of pro-
inﬂammatory cytokines by activating AP-1 [20]. Indeed, the cas-
pase-11 promoter [6] has putative AP-1 binding sequences when
scanned by several on-line promoter analysis programs such as
TFSEARCH or TESS. Therefore, it also remains to be determined
which transcription factor mediates the LPS–Ask1 signal to induce
caspase-11 gene.
Since caspase-11 can activate both inﬂammatory response by
pro-inﬂammatory cytokines and apoptosis under pathological
conditions [2,5], a detailed understanding of the mechanism of
its induction and activation can be a prerequisite for the develop-
ment of therapeutic strategy to inhibit pathological functions of
caspase-11 without interfering with its possible physiological
functions.
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